Decoy receptor 3 (DcR3) induces osteoclast formation from monocyte/macrophage lineage precursor cells (Q40582077)

21 September 2017

title

Decoy receptor 3 (DcR3) induces osteoclast formation from monocyte/macrophage lineage precursor cells (English)

1 reference

21 September 2017

1 reference

C R Yang

1

1 reference

21 September 2017

J H Wang

2

1 reference

21 September 2017

S L Hsieh

3

1 reference

21 September 2017

S M Wang

4

1 reference

21 September 2017

T L Hsu

5

1 reference

21 September 2017

W W Lin

6

1 reference

21 September 2017

publication date

1 July 2004

1 reference

Cell Death & Differentiation

21 September 2017

published in

1 reference

21 September 2017

volume

11 Suppl 1

1 reference

21 September 2017

page(s)

S97-107

1 reference

Human tumour-associated macrophages differentiate into osteoclastic bone-resorbing cells

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401403

Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401403

Origin of osteoclasts: mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401403

The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401403

Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401403

Bone resorption by osteoclasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401403

Cell biology of the osteoclast

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401403

Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401403

The effect of macrophage-colony stimulating factor and other humoral factors (interleukin-1, -3, -6, and -11, tumor necrosis factor-alpha, and granulocyte macrophage-colony stimulating factor) on human osteoclast formation from circulating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401403

Transforming growth factor beta affects osteoclast differentiation via direct and indirect actions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401403

The selective estrogen receptor modulator raloxifene regulates osteoclast and osteoblast activity in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401403

Activation of p38 mitogen-activated protein kinase is crucial in osteoclastogenesis induced by tumor necrosis factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401403

Tumor necrosis factor-alpha (TNF) stimulates RANKL-induced osteoclastogenesis via coupling of TNF type 1 receptor and RANK signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401403

Lipopolysaccharide-stimulated osteoclastogenesis is mediated by tumor necrosis factor via its P55 receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401403

Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401403

A newly identified member of tumor necrosis factor receptor superfamily (TR6) suppresses LIGHT-mediated apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401403

TL1A is a TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell costimulator

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401403

Overexpression of M68/DcR3 in human gastrointestinal tract tumors independent of gene amplification and its location in a four-gene cluster

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401403

Endogenous decoy receptor 3 blocks the growth inhibition signals mediated by Fas ligand in human pancreatic adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401403

Amplification and expression of a decoy receptor for fas ligand (DcR3) in virus (EBV or HTLV-I) associated lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401403

DCR3 locus is a predictive marker for 5-fluorouracil-based adjuvant chemotherapy in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401403

Clinical significance of detecting elevated serum DcR3/TR6/M68 in malignant tumor patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401403

The role of apoptosis signal-regulating kinase 1 in lymphotoxin-beta receptor-mediated cell death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401403

TL1, a novel tumor necrosis factor-like cytokine, induces apoptosis in endothelial cells. Involvement of activation of stress protein kinases (stress-activated protein kinase and p38 mitogen-activated protein kinase) and caspase-3-like protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401403

Soluble decoy receptor 3 induces angiogenesis by neutralization of TL1A, a cytokine belonging to tumor necrosis factor superfamily and exhibiting angiostatic action

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401403

Modulation of dendritic cell differentiation and maturation by decoy receptor 3

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401403

Enhanced adhesion of monocytes via reverse signaling triggered by decoy receptor 3

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401403

Reverse signaling through transmembrane TNF confers resistance to lipopolysaccharide in human monocytes and macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401403

TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401403

Reciprocal role of ERK and NF-kappaB pathways in survival and activation of osteoclasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401403

LIGHT, a new member of the TNF superfamily, and lymphotoxin alpha are ligands for herpesvirus entry mediator

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401403

Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401403

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401403

Enhanced RANK ligand expression and responsivity of bone marrow cells in Paget's disease of bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401403

Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401403

Regulation of TNF expression by multiple mitogen-activated protein kinase pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401403

Combinations of ERK and p38 MAPK inhibitors ablate tumor necrosis factor-alpha (TNF-alpha ) mRNA induction. Evidence for selective destabilization of TNF-alpha transcripts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401403

Osteopetrosis in mice lacking NF-kappaB1 and NF-kappaB2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401403

Activation of NF-kappaB by RANK requires tumor necrosis factor receptor-associated factor (TRAF) 6 and NF-kappaB-inducing kinase. Identification of a novel TRAF6 interaction motif

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401403

LIGHT, a novel ligand for lymphotoxin beta receptor and TR2/HVEM induces apoptosis and suppresses in vivo tumor formation via gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401403

HMG-CoA reductase inhibitors inhibit inducible nitric oxide synthase gene expression in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401403

Tumor necrosis factor-? mediates RANK ligand stimulation of osteoclast differentiation by an autocrine mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401403

Use of an in vivo model to determine the effects of interleukin-1 on cells at different stages in the osteoclast lineage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401403

7 January 2021

Tumor necrosis factor-alpha induces differentiation of and bone resorption by osteoclasts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401403

7 January 2021

Mouse T cells receive costimulatory signals from LIGHT, a TNF family member

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401403

7 January 2021

Modulation of macrophage differentiation and activation by decoy receptor 3

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401403

7 January 2021

Fas ligand costimulates the in vivo proliferation of CD8+ T cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401403

7 January 2021

A combination of osteoclast differentiation factor and macrophage-colony stimulating factor is sufficient for both human and mouse osteoclast formation in vitro

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401403

7 January 2021

Involvement of p38 mitogen-activated protein kinase signaling pathway in osteoclastogenesis mediated by receptor activator of NF-kappa B ligand (RANKL)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401403

7 January 2021

Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401403

7 January 2021

Nitric oxide is a regulator of bone remodelling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401403

7 January 2021

Extracellular signal-regulated kinase and p38 subgroups of mitogen-activated protein kinases regulate inducible nitric oxide synthase and tumor necrosis factor-alpha gene expression in endotoxin-stimulated primary glial cultures

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401403

7 January 2021

Activation of NF-kappaB is involved in the survival of osteoclasts promoted by interleukin-1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401403

7 January 2021

Enhanced proliferation and increased IFN-gamma production in T cells by signal transduced through TNF-related apoptosis-inducing ligand

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401403

7 January 2021

Enhanced secretion of IFN-gamma by activated Th1 cells occurs via reverse signaling through TNF-related activation-induced cytokine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401403

7 January 2021

Identifiers

DOI

10.1038/SJ.CDD.4401403

1 reference

Dimensions Publication ID

21 September 2017

1027576536

0 references

1 reference